Market Cap 1.72M
Revenue (ttm) 0.00
Net Income (ttm) -7.52M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 53,100
Avg Vol 78,262
Day's Range N/A - N/A
Shares Out 1.65M
Stochastic %K 9%
Beta 0.49
Analysts Hold
Price Target $12.00

Company Profile

Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 3 693 8448
Fax: 972 3 693 8447
Address:
16 Abba Hillel Road, Ramat Gan, Israel
Shakattack31
Shakattack31 Nov. 16 at 8:27 PM
$GLMD @lookgoodplaygood22 are you done pushing this shitty stock?
1 · Reply
getsometoday
getsometoday Nov. 16 at 8:22 PM
$GLMD what happened to all the prs and the 💩talk from mgmt. I want to know how much cash is on the balance sheet. Dang it.
0 · Reply
Lowlyme
Lowlyme Nov. 15 at 2:01 AM
$GLMD Held since 2020. Still holding.
1 · Reply
Lowlyme
Lowlyme Nov. 15 at 2:00 AM
$GLMD Waiting on a response. Anyone?
1 · Reply
JamoTries2Trade
JamoTries2Trade Nov. 15 at 12:28 AM
$GLMD perfect
0 · Reply
madan_shatri
madan_shatri Nov. 14 at 4:47 PM
$GLMD wil it recover back to $1.60s range ? way too much down. Very difficult to go back to that range without a significant update. IMO, any crypto update will be irrelevant now. JMHO Its way too much down to go back to $1.60s range. Since its end of the year, not much significant investment will come into these types of stocks unless there is clarity on future courses of action by the company. Nearllg 28% down from intradag high on SHs meeting day, just 13 trading days from Oct 28th
3 · Reply
getsometoday
getsometoday Nov. 14 at 4:31 PM
$GLMD I hope they didn’t buy crypto.
1 · Reply
Mattherhorn
Mattherhorn Nov. 14 at 4:02 PM
$GLMD Forgot that foreign companies listed on American exchanges don't adhere to the same reporting timelines as american companies. So they don't have to file today.
0 · Reply
BankOnTheFuture
BankOnTheFuture Nov. 14 at 3:34 PM
$GLMD Throughout this market selloff, the XBI (S&P Biotech ETF) has been UP. Big pharma needs new molecules for their product lines to keep that momentum going. Like interim Phase 3 positive published data Aramchol. Allen, you know GLMD is too small to complete the clinical trial... sell the company.
1 · Reply
David_M_
David_M_ Nov. 14 at 3:00 PM
0 · Reply
Latest News on GLMD
Shakattack31
Shakattack31 Nov. 16 at 8:27 PM
$GLMD @lookgoodplaygood22 are you done pushing this shitty stock?
1 · Reply
getsometoday
getsometoday Nov. 16 at 8:22 PM
$GLMD what happened to all the prs and the 💩talk from mgmt. I want to know how much cash is on the balance sheet. Dang it.
0 · Reply
Lowlyme
Lowlyme Nov. 15 at 2:01 AM
$GLMD Held since 2020. Still holding.
1 · Reply
Lowlyme
Lowlyme Nov. 15 at 2:00 AM
$GLMD Waiting on a response. Anyone?
1 · Reply
JamoTries2Trade
JamoTries2Trade Nov. 15 at 12:28 AM
$GLMD perfect
0 · Reply
madan_shatri
madan_shatri Nov. 14 at 4:47 PM
$GLMD wil it recover back to $1.60s range ? way too much down. Very difficult to go back to that range without a significant update. IMO, any crypto update will be irrelevant now. JMHO Its way too much down to go back to $1.60s range. Since its end of the year, not much significant investment will come into these types of stocks unless there is clarity on future courses of action by the company. Nearllg 28% down from intradag high on SHs meeting day, just 13 trading days from Oct 28th
3 · Reply
getsometoday
getsometoday Nov. 14 at 4:31 PM
$GLMD I hope they didn’t buy crypto.
1 · Reply
Mattherhorn
Mattherhorn Nov. 14 at 4:02 PM
$GLMD Forgot that foreign companies listed on American exchanges don't adhere to the same reporting timelines as american companies. So they don't have to file today.
0 · Reply
BankOnTheFuture
BankOnTheFuture Nov. 14 at 3:34 PM
$GLMD Throughout this market selloff, the XBI (S&P Biotech ETF) has been UP. Big pharma needs new molecules for their product lines to keep that momentum going. Like interim Phase 3 positive published data Aramchol. Allen, you know GLMD is too small to complete the clinical trial... sell the company.
1 · Reply
David_M_
David_M_ Nov. 14 at 3:00 PM
0 · Reply
getsometoday
getsometoday Nov. 14 at 2:59 PM
$GLMD drop some news. We are going non compliant.
0 · Reply
Morpomex
Morpomex Nov. 14 at 2:58 PM
$GLMD Wonder why the huge selling the last few days. Dang. This is brutal.
0 · Reply
madan_shatri
madan_shatri Nov. 14 at 2:26 PM
$GLMD looks like bloodbath continues today. Already 11% down in pre market Never seen such a consistent & big daily declines before in any stock where there is no big negative factor wow ! Pre market $0.95
0 · Reply
dln101
dln101 Nov. 14 at 2:20 PM
$GLMD $PRSO $TNON time to add 🤔
0 · Reply
Morpomex
Morpomex Nov. 14 at 1:48 PM
$GLMD This got to be oversold down here right??
0 · Reply
madan_shatri
madan_shatri Nov. 14 at 8:50 AM
$GLMD Please stop this decline 🙏. Lets bring it back to $1.50s before major news hits the deck. Lost way too much of its valuation in last 2 weeks. Daily non stop avg decline of 5% to 7% is way too much. Doesn't deserve this 🙏 Someowhere it gotta be stopped !
0 · Reply
Mattherhorn
Mattherhorn Nov. 13 at 11:17 PM
$GLMD 10Q tomorrow, right?
1 · Reply
madan_shatri
madan_shatri Nov. 13 at 7:17 PM
$GLMD Cheer for GREEN CLOSE !!
0 · Reply
Shakattack31
Shakattack31 Nov. 13 at 6:33 PM
$GLMD 🫠
0 · Reply
Trumpy14
Trumpy14 Nov. 13 at 6:16 PM
$GLMD where is the bottom here?
1 · Reply
BankOnTheFuture
BankOnTheFuture Nov. 13 at 5:49 PM
$GLMD The risk to reward ratio is enormous to short this and the shorts know it. GLMD could sell its Phase 3, positive published results Aramchol molecule to big pharma tomorrow. Even a sale price if $100M which is below bargain basement means $20/share. 750M plus is a more likely number. The math doesn't math for the present share price
2 · Reply
Morpomex
Morpomex Nov. 13 at 4:46 PM
$GLMD I’m doing my buying down here. Good prices.
0 · Reply